Abstract
AbstractThis replication study assesses the long-term effects of MiFID II’s research unbundling rules on investment research provision and stock market quality. We extend existing studies by utilizing a post-event period exceeding five years, by regional differentiation within Europe, and by incorporating the new option to rebundle payments for order execution and research services for SMEs. In line with existing studies, we find a decrease in analyst coverage after MiFID II, particularly for large caps, while SMEs remain unaffected. These findings are consistent across different European regions but not for the United Kingdom. Market quality experiences a decline, with lower trading volume and increased volatility, offset by liquidity improvements for larger firms. After the introduction of rebundling, which has not been analyzed by existing studies, SME research coverage declines, suggesting that investment firms are not utilizing this option. Our findings offer insights for evidence-based policy-making as regulatory discussions on research unbundling persist in different jurisdictions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
